Glucosamine supplements may speed memory loss from Alzheimer’s, new research shows
In The Conversation, Dr. Ramon Sun discusses his study reporting an increased mortality risk among Alzheimer's patients using Glucosamine.
In The Conversation, Dr. Ramon Sun discusses his study reporting an increased mortality risk among Alzheimer's patients using Glucosamine.
In The Conversation, Dr. Joe Abisambra details the first evidence linking key proteins in the development of progressive supranuclear palsy.
In The Conversation, Dr. Rachael Seidler discusses new research showing that the brain shifts upward and backward, and deforms within the skull, after spaceflight.
In The Conversation, Drs. Habibeh Khoshbouei and Marcelo Febo discuss their new study paving the way to test immune-modulating medicines as a potential tool to break the cycle of meth addiction.
In The Conversation, Christiano Marconi discusses a new study in Nature finding that the COVID-19 mRNA vaccine sparks an immune response to fight cancer.
In The Conversation, Dr. Carol Mathews discusses the trend of rising ADHD diagnoses and what this means.
In The Conversation, Dr. Carol Mathews explains her new study in Nature Genetics shedding light on the genetics of OCD.
In The Conversation's Curious Kids series, Dr. Yenisel Cruz-Almeida explains pain, how it travels, and why it's needed as a warning signal.
In The Conversation, Dr. Diego Rincon-Limas discusses the role brain inflammation may play in muscle fatigue in cases of long COVID, Alzheimer's, or E. coli infections
In The Conversation, Drs. Natalie Ebner and Didem Pehlivanoglu discuss the factors that shape vulnerability to scams in older adults.